Animals
Ten-week-old female Nod/ltj mice and ICR mice (from which the NOD/ltj strain was derived) were purchased from Liaoning Changsheng Biotechnology Co., Ltd. (Liaoning, China). Mice were maintained for 2 weeks, and 12-week-old Nod/ltj mice and ICR mice were used in this study. All animal experiment protocols were approved by the Institutional Animal Care and Use Committee of China Medical University (2020302).
Antibodies and reagents
Anti-CD9, anti-Alix, anti-calnexin, fluorescein isothiocyanate (FITC)-labelled anti-CD31, anti-CD34, anti-CD45, anti-CD90, anti-CD105, IgG isotype control, phycoerythrin (PE) -labelled anti-CD73 and IgG isotype control antibodies were purchased from Abcam (Cambridge, UK). Human FITC-labelled anti-CD4, human allophycocyanin (APC)-labelled anti-IL-17A, mouse FITC-labelled anti-CD4 and mouse PE-labelled anti-IL-17A antibodies were purchased from BD Biosciences (CA, USA). CD63 antibody and Alexa Fluor 488- and Alexa Fluor 568-conjugated secondary antibodies were purchased from Proteintech (Rosemont, IL, USA). PKH-67 kits were purchased from Sigma-Aldrich (St. Louis, MO, USA). Lipofectamine 3000 was purchased from Thermo Fisher (Eugene, Oregon, USA). The hsa-piR-15254 mimics, inhibitor and negative control were purchased from GenePharma (Suzhou, China).
SCAP isolation and identification
Ethics approval was obtained from the ethics committee of the School of Stomatology, China Medical University (202012), and written informed consent was obtained from all the participants. SCAP were collected from intact, caries-free impacted third molars with immature roots extracted from three healthy human patients (12–15 years of age) at the dental clinic of the School of Stomatology affiliated with the China Medical University. Dispase II (Boehringer Ingelheim, Mannheim, Germany) and collagenase type I (Worthington Biochemical Co., Lakewood, CO, USA) were used to digest the apical papilla. The cells were seeded in 10-cm culture dishes and cultured with alpha minimum essential medium (a-MEM; HyClone) supplemented with 15% foetal bovine serum (FBS; MRC BRL), 2 mM L-glutamine (Biosource/Invitrogen), 100 U/mL penicillin-streptomycin (HyClone), and 0.1 mM L-ascorbic acid 2-phosphate (WAKO, Japan) and maintained in a humidified atmosphere containing 5% CO2 at 37 ℃. SCAP at passage 5 were used for subsequent experiments.
Anti-human CD73 antibody labelled with PE and anti-human CD31, CD34, CD45, CD90, and CD105 (1:100; Abcam) antibodies labelled with FITC were used to detect the surface marker expression on SCAP. The expression of each surface marker was tested by flow cytometry (Becton Dickinson, Islandia, NY). The multiple differentiation potential of SCAP was evaluated by culturing the cells in adipogenic, osteogenic differentiation medium for 4 weeks and neurogenic differentiation medium for 2 weeks, followed by oil red O staining, Alizarin red S staining, and βⅢ-tubulin immunofluorescence, respectively.
SCAP-Exo isolation and identification
According to our previously published protocol, ultracentrifugation was used to separate and purify exosomes [16]. Briefly, when the 5th passage SCAP reached 80% confluence, the cells were washed three times with phosphate-buffered saline (PBS), and the supernatant was collected after 48 h of continuous culture in exosome-free serum medium (SBI, USA). The exosome purification procedure was based on differential ultracentrifugation at 4 ℃. The culture supernatants were centrifuged successively at increasing speeds: 3,000 × g for 20 min, 20,000 × g for 30 min, and 120,000 × g for 2 h (Beckman Optima L-100XP, USA). The isolated exosomes were resuspended in sterile PBS and stored at -80 ℃.
To verify the presence of SCAP-Exo in the isolates, transmission electron microscopy (TEM), NanoSight tracking analysis (NTA) and western blotting were performed, and SCAP-Exo identification was carried out according to the MISEV 2018 guidelines [23]. TEM (H-800, Hitachi, Japan) was performed to observe the shapes of exosomes. A NTA system (ZetaView, Germany) was employed to determine the sizes of the particles. SCAP-Exo were incubated with RIPA lysis buffer (Beyotime Biotech Co., Shanghai, China) on ice for 1 h, and their concentrations were measured by a BCA protein assay kit (Beyotime Biotech Co., Shanghai, China). The exosomes were quantified as described in our previous study. For western blotting analysis, 20 μg of each SCAP lysate or SCAP-Exo lysate sample were loaded and separated by 10% SDS-PAGE. The proteins were transferred to polyvinylidene difluoride membranes and then blotted with antibodies against Alix (1:500; Abcam), CD9 (1:500; Abcam), CD63 (1:500; Proteintech), or calnexin (1:500; Abcam). The protein bands were detected with an Odyssey CLx instrument (LI-COR, Lincoln, NE).
Transplantation of SCAP-Exo to SS mice
Female NOD/ltj mice, which suffer from dry mouth, dry eye and histopathological changes in the salivary glands and peripheral blood, are the most widely used model of SS and were used in this study; ICR mice served as a control [24]. NOD/ltj mice were injected via tail vein twice with 20 μg SCAP-Exo (n = 6) or PBS (n = 6), and ICR mice were injected with PBS (n = 6) at 12 and 14 weeks of age. At 16 weeks of age, mice were euthanized to collect spleen, peripheral blood, and submandibular gland samples.
Measurement of saliva flow rates
Mice were anaesthetized with 2.4% pentobarbital (100 μL/20 g body weight). Saliva was then collected on a cotton ball for 10 min under pilocarpine stimulation (0.2 mg/kg body weight, injected subcutaneously). The weight of the cotton ball was measured before and after saliva collection. Saliva weight was converted into saliva volume, assuming that 1 g represents 1 μL [25]. The amount of saliva was normalized to grams of body weight per 10 min.
Haematoxylin-eosin (H&E) and immunofluorescence staining
The submandibular glands were fixed in 4% buffered formaldehyde, embedded in paraffin, sectioned (5 μm thick), and stained with H&E. Inflammatory infiltrates in the submandibular glands were quantified according to the Chisholm–Mason classification criteria [26]. A portion of these submandibular glands was embedded in optimal cutting temperature compound, and 7-µm-thick sections were mounted on slides using a cryostat. To detect the infiltration of Th17 cells in the submandibular gland, frozen sections were subjected to immunofluorescence analysis for CD4 and IL-17A, which are matrix markers of Th17 cells.
Isolation of peripheral blood mononuclear cells and CD4+ T lymphocytes
Human peripheral blood from three healthy donors and their peripheral blood mononuclear cells (PBMCs) were purified by Ficoll density-gradient centrifugation. Then human CD4+ T lymphocytes were purified by negative selection from PBMCs using a CD4+ T cell isolation kit (Miltenyi Biotec, Auburn, CA) according to the manufacturer’s instructions with MACS LD (Miltenyi Biotec, Auburn, CA) and a MidiMACS magnetic separator (Miltenyi Biotec, Auburn, CA). Then, CD4+ T lymphocytes (1 × 106 per well) were cultured on 24-well multiplates (Corning) in complete medium. The complete medium consisted of Dulbecco’s modified Eagle’s medium (DMEM, Lonza) supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 50 mM 2-mercaptoethanol, 100 U/mL penicillin and 100 µg/ml streptomycin. Human CD4+ T lymphocytes were used for the in vitro studies.
Th17 induction assay in SCAP-Exo co-culture
Induction of human Th17 cells was performed as previously reported [27, 28]. CD4+ T lymphocytes were precultured on 24-well multiplates (1 × 106 per well) in complete medium in the presence of plate-bound anti-CD3 antibody (5 µg/mL), soluble anti-CD28 antibody (2 µg/mL), recombinant human transforming growth factor-β1 (TGF-β1) (2 ng/mL) and recombinant human IL-6 (50 ng/mL) (R&D Systems). To determine the effect of SCAP-Exo on Th17 cell differentiation in vitro, different concentrations of SCAP-Exo (20 µg/mL, 40 µg/mL) were added to the wells. After 3 days, floating cells and culture medium were collected and centrifuged. The cells were subjected to flow cytometry to analyse the proportion of Th17/CD4+ T cells, and the IL-17A levels in the supernatant were measured by enzyme-linked immunosorbent assay (ELISA).
Endocytosis experiments
SCAP-Exo were labelled with the PKH-67 Labelling Kit (Sigma, USA) according to the manufacturer’s protocol. PKH-67-labelled exosomes were cocultured with 1 × 106 CD4+ T cells in a 24-well multiplate for 6 h at 37 ℃ and 5% CO2. Subsequently, CD4+ T cells were fixed in 4% paraformaldehyde (PFA) solution, and the nuclei were stained with DAPI (Beyotime Institute of Biotechnology, China). The labelled exosomes in the CD4+ T cells were imaged under a fluorescence microscope.
Bioinformatics analysis
In this experiment, we identified the most highly expressed piRNAs in SCAP-Exo and predicted their target genes by miRanda (v3.3a, www.microrna.org/microrna/home.do) and RNAhybrid (http://bibiserv.techfak.unibielefeld.de/rnahybrid). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was then performed to determine the participation of these target genes in different biological pathways and to determine the targets of piRNAs related to this study and their potential binding sites.
Firefly luciferase and Renilla luciferase assays
For the firefly luciferase and Renilla luciferase assays, 293T cells were seeded in a 96-well plate, cultured to 70% confluence, and transfected with either the IL-6R-3’UTR plasmid or hsa-piR-15254/negative control (GenePharma, China). The cells were transfected using Lipofectamine 3000 (Invitrogen, USA) and collected 48 h later. Luciferase activity in cell lysates was determined with a Dual-Luciferase Reporter Assay System (Promega, USA) according to the manufacturer’s instructions. Firefly luciferase and Renilla luciferase activities were detected on a Veritas Microplate Luminometer (Promega, USA). The ratio of firefly luciferase to Renilla luciferase was calculated and normalized for each sample.
Transfection of hsa-piR-15254
CD4+ T cells were seeded on 24-well multiplates (1 × 106 per well) the day before transfection. The cells were transfected with 50 nM hsa-piR-15254 mimic, 100 nM hsa-piR-15254 inhibitor, or the negative control (hsa-piR-15254-mimic-NC or hsa-piR-15254-inhibitor-NC) using Lipofectamine 3000 transfection reagent in 2 mL of α-MEM according to the manufacturer’s instructions. Six hours later, the medium was removed, and the cells were washed three times with PBS and cultured with complete medium.
The transfected sequences were as follows: hsa-piR-15254 mimic (sense, 5’-UGUAGUGCGCUAUGCCGAUCGGGUGUCCCC-3’; antisense, 5’-GGACACCCAUCGGCAUACGACUAGAUU-3’), hsa-piR-15254 inhibitor (sense, 5’-GGGGACACCCAUCGGCAUACGACUAGA-3’), mimic negative control (sense, 5’-UUCUCCGAACGUGUCACGUUU-3’; antisense, 5’-AAACGUGACGUUCGGAGAA-3’), and inhibitor negative control (sense, 5’-AAACGUGACGUUCGGAGAA-3’). All oligos were synthesized by Suzhou GenePharma Gene Co. Ltd. (Suzhou, China).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
For gene expression analysis, cells were collected and washed three times with PBS and then lysed in RNAiso Plus (Takara, Japan). Total RNA was isolated and reverse-transcribed using the PrimeScript™ RT Reagent Kit with gDNA Eraser (Takara, Japan) to obtain cDNA. For piRNA expression analysis, after RNA isolation, first-strand cDNA was synthesized via reverse transcription using the Mqklir-X™ miRNA First Strand Synthesis Kit (Takara, Japan) according to the manufacturer’s instructions. RT-qPCR was then carried out on a Bio-Rad real-time PCR system (CFXConnect, USA) for 40 cycles with Power TB Green PCR Master Mix (Takara, Japan). The expression levels of the target genes were normalized to that of the control housekeeping gene GAPDH, and piRNA expression was normalized to that of U6. Gene expression data were analysed by the 2−ΔΔCt method. The primer sequences are listed in Table 1.
Flow cytometry analysis for Th17 cell detection
Human CD4+ T cells were incubated with the relevant anti-human antibodies to characterize Th17 cell subsets: FITC-CD4 and APC-IL-17A. To characterize mice Th17 cells, peripheral blood was collected from the orbital vein, and PBMCs was separated using erythrocyte lysis. Moreover, we isolated splenic PBMCs from mice. A single-cell suspension was collected by mincing mice spleen tissues through a 70 μm strainer, followed by erythrocyte lysis. Then, PBMCs from the spleen and peripheral blood were stained with FITC-CD4 and PE-IL-17A anti-mouse antibodies to identify Th17 cells. The stained cells were assayed by flow cytometry (Becton Dickinson, Islandia, NY), and the data were analysed with FlowJo software (FlowJo LLC, version 10.6.0).
IL-17A ELISA
Culture supernatant was collected from the coculture of SCAP-Exo with activated CD4+ T cells. Blood serum was obtained from peripheral blood collected from NOD/ltj and ICR mice. All samples were stored at -80 ℃ until use and recentrifuged before ELISA. The expression levels of IL-17A were measured according to the manufacturer's protocols for the human and mouse IL-17A enzyme-linked immunosorbent assay kits (BD Biosciences).
Statistical analysis
Three biological replicates were performed for all procedures to verify the results. The data were recorded as the mean ± standard deviation (SD). Comparisons between two groups were analysed using an independent two-tailed Student’s t test, and comparisons among more than two groups were performed using one-way analysis of variance (ANOVA) with SPSS 20.0 software (SPSS Inc., Chicago, IL, USA). A value of P < 0.05 was considered to indicate statistical significance.